Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Delabie

Showing results (91-100 of 179) with videos related to

Pageof 18
Sort By:
British Journal of Haematology|June 25, 2016
The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab eraYngvild Nuvin Blaker, Signe Spetalen, Marianne Brodtkorb, et al.
Blood|January 9, 2013
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cellsJune H Myklebust, Jonathan M Irish, Joshua Brody, et al.
Leukemia & Lymphoma|October 10, 2009
Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IVSarah T Wilkinson, Diane R Fernandez, Shawn P Murphy, et al.
Leukemia & Lymphoma|July 16, 2005
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphomaYouli Zu, Seth M Steinberg, Elias Campo, et al.
Plos One|March 15, 2014
Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphomaMinna Taskinen, Riku Louhimo, Satu Koivula, et al.
Blood|December 25, 2016
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profilingJune H Myklebust, Joshua Brody, Holbrook E Kohrt, et al.
Blood Cancer Journal|December 16, 2017
MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphomaSuvi-Katri Leivonen, Katherine Icay, Kirsi Jäntti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissuesLisa M Rimsza, George Wright, Mark Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximabPaul N Meyer, Kai Fu, Timothy C Greiner, et al.
American Journal of Clinical Pathology|January 29, 2013
Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphomaCarlo Valentino, Samantha Kendrick, Nathalie Johnson, et al.
Pageof 18

Showing results (91-100 of 179) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|June 25, 2016
The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab eraYngvild Nuvin Blaker, Signe Spetalen, Marianne Brodtkorb, et al.
Blood|January 9, 2013
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cellsJune H Myklebust, Jonathan M Irish, Joshua Brody, et al.
Leukemia & Lymphoma|October 10, 2009
Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IVSarah T Wilkinson, Diane R Fernandez, Shawn P Murphy, et al.
Leukemia & Lymphoma|July 16, 2005
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphomaYouli Zu, Seth M Steinberg, Elias Campo, et al.
Plos One|March 15, 2014
Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphomaMinna Taskinen, Riku Louhimo, Satu Koivula, et al.
Blood|December 25, 2016
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profilingJune H Myklebust, Joshua Brody, Holbrook E Kohrt, et al.
Blood Cancer Journal|December 16, 2017
MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphomaSuvi-Katri Leivonen, Katherine Icay, Kirsi Jäntti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissuesLisa M Rimsza, George Wright, Mark Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximabPaul N Meyer, Kai Fu, Timothy C Greiner, et al.
American Journal of Clinical Pathology|January 29, 2013
Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphomaCarlo Valentino, Samantha Kendrick, Nathalie Johnson, et al.
Pageof 18